Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

412
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
412
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

352
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
352
Analgesia and Pain Management01:25

Analgesia and Pain Management

779
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
779
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

641
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
641
Drug Dependence01:17

Drug Dependence

1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supportive Text Messaging was Associated with Reduced Health Service Utilization Costs in the 6 Months Following Psychiatric Admission: An Exploratory Secondary Analysis of a Stepped-Wedge Cluster Randomized Trial.

JMIR mental health·2026
Same author

A Retrospective Cohort Study Assessing the Impact of Dexmedetomidine on Prognosis in Mechanically Ventilated Sepsis Patients.

Journal of intensive care medicine·2026
Same author

Short-chain fatty acids of intestinal origin attenuate protein-bound uremic toxins in patients with chronic kidney disease by protecting the intestinal barrier: a pooled analysis of multiple studies with individualized intervention strategies.

BMC gastroenterology·2026
Same author

Patient perspectives on barriers to rTMS for peripartum depression.

BMC psychiatry·2026
Same author

Emergency departments can and should be a 'safe place' for mental health crisis patients to wait for care.

Evidence-based nursing·2026
Same author

3MDR Therapy Reduces Symptoms of PTSD and Related Conditions in Canadian Military Members and Veterans, Public Safety Personnel, and Clinical Personnel.

Brain and behavior·2026

Related Experiment Video

Updated: Sep 3, 2025

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
14:56

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP

Published on: January 27, 2010

21.5K

Individualized Prospective Prediction of Opioid Use Disorder.

Yang S Liu1,2, Lawrence Kiyang2, Jake Hayward3

  • 1Department of Psychiatry, 3158University of Alberta, Edmonton, Alberta, Canada.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|July 27, 2022
PubMed
Summary

Machine learning accurately predicts opioid use disorder (OUD) prospectively using large health datasets. This approach is vital for early OUD detection and intervention in clinical settings.

Keywords:
administrative health dataelectronic health recordsmachine learningopioid use disorderprospective validation

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.3K

Related Experiment Videos

Last Updated: Sep 3, 2025

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
14:56

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP

Published on: January 27, 2010

21.5K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.3K

Area of Science:

  • Public Health
  • Data Science
  • Clinical Informatics

Background:

  • Opioid use disorder (OUD) affects millions globally, necessitating early detection and intervention strategies.
  • Existing machine learning (ML) models for OUD prediction often lack validation on representative data and prospective testing.
  • This limits their real-world applicability for identifying new OUD cases.

Purpose of the Study:

  • To develop and prospectively validate a machine learning model for predicting individual opioid use disorder (OUD) cases.
  • To utilize representative, large-scale Canadian administrative health data for model development and validation.
  • To assess the model's accuracy in predicting future OUD cases.

Main Methods:

  • An ensemble machine-learning model was developed using administrative health data from 2014-2018 (n=699,164).
  • Model performance was validated on a hold-out sample (2014-2018, n=174,791) and prospectively on a 2019 sample (n=316,039).
  • Opioid use disorder (OUD) diagnosis was based on International Classification of Diseases (ICD) codes.

Main Results:

  • The model prospectively predicted OUD cases in 2019 with high accuracy (balanced accuracy: 86%, sensitivity: 93%, specificity: 79%).
  • Top risk factors identified included indicators of opioid use and a history of other substance use disorders.
  • The study identified 6409 OUD cases in the 2019 prospective sample.

Conclusions:

  • This study demonstrates the feasibility of individualized, prospective OUD prediction using ML on large administrative health datasets.
  • Prospective prediction models are crucial for advancing early detection of OUD in clinical practice.
  • The findings support the potential of ML-driven tools for timely OUD intervention.